Tumor Microenvironment-Adjusted Prognostic Implications of the KRAS Mutation Subtype in Patients with Stage III Colorectal Cancer Treated with Adjuvant FOLFOX

Considering the effect of KRAS mutations on tumor microenvironment, investigators analyzed the prognostic significance of KRAS mutation types after adjusting for the tumor-infiltrating lymphocytes and tumor-stromal percentage statuses.